1Shelburne SA 3rd, Hamill RJ, Rodríguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine(Baltimore), 2002, 81:213-227.
2Cheng VC, Yuen KY, Chan WM, et al. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis, 2000, 30:882-892.
3French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS, 2004, 18:1615-1627.
4Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD+4 T-cell homeostasis and function in advanced HIV disease. Science, 1997, 277:112-116.
5Li TS, Tubiana R, Katlama C, et al. Long lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet, 1998, 351:1682-1686.
6Lederman MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trails Group Protocol 315. J Infect Dis, 1998, 178:70-79.
7Carter EJ, Mates S. Sudden enlargement of a deep cervical lymph node during and after treatment for pulmonary tuberculosis. Chest, 1994, 106:1896-1898.
8Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis, 1994, 19:1092-1099.
9Mallal SA, James IR, French MA. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine. AIDS, 1994, 8:1263-1269.
10Shelburne SA 3rd, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev, 2003, 5:67-79.
